Showing results (361-370 of 390) with videos related to
Sort By:
Pageof 39
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Discovery of triazolopyrimidine-based PDE8B inhibitors: exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetesMichael P DeNinno, Stephen W Wright, John B Etienne, et al.Immunohematology|May 7, 2021
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assayA D Ho, H Verkerke, J W Allen, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaquesRabih Halwani, Jean D Boyer, Bader Yassine-Diab, et al.Frontiers in Immunology|June 23, 2025
Intramuscular DNA vaccine provides protection in non-human primate and mouse models of SARS-CoV-2Subeena Sood, Ebony N Gary, Majed Matar, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell helpMichele A Kutzler, Tara M Robinson, Michael A Chattergoon, et al.Science Translational Medicine|October 12, 2012
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responsesMark L Bagarazzi, Jian Yan, Matthew P Morrow, et al.Bioorganic & Medicinal Chemistry Letters|March 12, 2009
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitorMark J Ammirati, Kim M Andrews, David D Boyer, et al.ACS Medicinal Chemistry Letters|August 22, 2025
Pharmacokinetic and Biodistribution Studies of [<sup>18</sup>F]-Taccalonolide: A Covalent Microtubule Stabilizer with Antitumor EfficacyLuke N Jaskowski, Nicholas A Clanton, Nancy J Wilkinson, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2004
Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas?V Trillet-Lenoir, F Chapuis, S Touzet, et al.Vaccine|January 12, 2012
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challengeJosephine H Cox, Maria G Ferrari, Patricia Earl, et al.Pageof 39